Credit Suisse (SIX:CSGN) analyst Jailendra Singh maintained a Buy rating on Ehealth (NASDAQ:EHTH) on Thursday, setting a price target of $174, which is approximately 57.27% above the present share price of $110.64.
Singh expects Ehealth to post earnings per share (EPS) of $0.14 for the second quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Strong Buy rating of shares in Ehealth, with an average price target of $178.89.
The analysts price targets range from a high of $250 to a low of $150.
In its latest earnings report, released on 03/31/2020, the company reported a quarterly revenue of $106.41 million and a net profit of $1.03 million. The company's market cap is $2.66 billion.
According to TipRanks.com, Credit Suisse analyst Jailendra Singh is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 3.5% and a 55.56% success rate.
eHealth , Inc. engages in the provision of Internet-based health insurance agency services for individuals, families, and small businesses. It operates through the Medicare and Individual, Family, and Small Business segment. The Medicare segment consists primarily of commissions earned from sale of Medicare-related health insurance plans. The Individual, Family, and Small Business segment includes commissions earned from the sale of individual and family and small business health insurance plans and ancillary products sold to non-Medicare-eligible customers. The company was founded by Vipool Mohanlal Patel in November 14, 1997 and is headquartered in Mountain View, CA.